News
Stock futures declined Monday after the S&P 500 closed higher on Friday for the ninth session in a row, the index’s longest ...
You’ve probably been there — staring at another diet plan, another gym ad, another promise of results. And if you’ve ever ...
Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...
On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...
We recently compiled a list of the 12 Best Stocks to Buy and Hold For 10 Years. In this article, we are going to take a look ...
This report covers recent developments in the health sector, including proposed US federal budget cuts affecting scientific ...
The Trump administration proposes significant budget cuts affecting health and research sectors. Texas reports 683 measles cases amid nationwide outbreaks. Medical device demand boosts Stryker's ...
When the stock market experiences a sharp decline, as it did after the Trump administration announced tariffs on its trade ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.
PRESS RELEASE FROM THE MINISTRY OF HEALTH AND HUMAN SERVICES Cockburn Town, Turks and Caicos Islands, 2nd May 2025: In ...
Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on the ...
A decision is expected in the fourth quarter of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results